Tenon Medical EPS TNON
Diluted earnings per share by quarter and over the last twelve months, from 2021.
- Last 12 months, to Jun 30, 2026
- −$25.65
- Latest quarter, Q2 FY26
- −$12.35
- Fiscal year 2025
- −$1.56
Tenon Medical's earnings per share was −$25.65 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$12.35.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.56 | n/a |
| FY2024 | −$797.65 | n/a |
| FY2023 | −$921345.95 | n/a |
| FY2022 | −$11236.40 | n/a |
| FY2021 | −$21336.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$12.35 | n/a | −$25.65 | |
| Q1 FY26 | $10.85 | −69% | −$26.06 | |
| Q4 FY25 | −$10.15 | n/a | −$1.56 | |
| Q3 FY25 | −$14.00 | n/a | −$25.71 | |
| Q2 FY25 | −$12.76 | n/a | −$138.76 | |
| Q1 FY25 | $35.35 | n/a | −$411.60 | |
| Q4 FY24 | −$34.30 | n/a | −$797.65 | |
| Q3 FY24 | −$127.05 | n/a | −$1110.55 | |
| Q2 FY24 | −$285.60 | n/a | −$1392.65 | |
| Q1 FY24 | −$350.70 | n/a | −$920492.65 | |
| Q4 FY23 | −$347.20 | n/a | −$921345.95 | |
| Q3 FY23 | −$409.15 | n/a | −$922967.15 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Tenon Medical's size, closest first, today.
| Company | EPS, 12 months |
|---|---|
| TNONTenon Medical | −$25.65 |
| BBLGBone Biologics | −$1.41 |
| IVFINVO Fertility | n/m |
| AMIXAutonomix Medical | n/m |
| NXGLNexgel | −$14.20 |
| ADGMAdagio Medical | −$1.43 |
| VJETFlyte Aviation | n/m |
| XAIRBeyond Air | −$68.40 |
| VVOSVivos Therapeutics | −$1.88 |
| CODXCo-Diagnostics | −$24.03 |
| BJDXBluejay Diagnostics | −$34.72 |
| Peer median | −$14.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Tenon Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.